Cross Staff Investments’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$567K Hold
4,800
0.32% 75
2026
Q1
$574K Hold
4,800
0.29% 69
2025
Q4
$654K Hold
4,800
0.36% 66
2025
Q3
$708K Hold
4,800
0.49% 56
2025
Q2
$621K Hold
4,800
0.46% 66
2025
Q1
$573K Hold
4,800
0.43% 65
2024
Q4
$557K Hold
4,800
0.39% 65
2024
Q3
$648K Hold
4,800
0.5% 57
2024
Q2
$651K Hold
4,800
0.54% 52
2024
Q1
$620K Hold
4,800
0.52% 55
2023
Q4
$549K Hold
4,800
0.49% 58
2023
Q3
$437K Sell
4,800
-200
-4% -$20.6K 0.43% 66
2023
Q2
$563K Buy
+5,000
New +$529K 0.52% 58

Other funds holding XYL

Cross Staff Investments's XYL Position: Q2 2026 in Review

Cross Staff Investments held its Xylem (XYL) position steady in Q2 2026 at 4,800 shares worth $567K. The position accounts for 0.32% of the portfolio, ranked #75.

Cross Staff Investments first reported a position in XYL in Q2 2023 and has held it in 13 quarters since. The position peaked at $708K in Q3 2025. 431 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cross Staff Investments held 4,800 shares of Xylem worth $567K as of Q2 2026.
  • Cross Staff Investments left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.32% of Cross Staff Investments's portfolio in Q2 2026, its #75 holding.
  • Cross Staff Investments first reported a position in Xylem in Q2 2023 and has held it in 13 quarters since.
  • Cross Staff Investments's Xylem position peaked at $708K in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.